Your session is about to expire
← Back to Search
CNU intervention for Sexually Transmitted Diseases (CNU Trial)
N/A
Waitlist Available
Led By Elwin Wu, PhD
Research Sponsored by Columbia University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 months
Awards & highlights
CNU Trial Summary
This trial will test whether a 7-session intervention can reduce HIV/STI risk behaviors and drug use compared to a wellness promotion control intervention.
Eligible Conditions
- Sexually Transmitted Diseases
- HIV/AIDS
CNU Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 12 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 months
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Difference in number of unprotected acts of anal intercourse between 2 groups
Secondary outcome measures
Difference in incidence of sexually transmitted infections (STIs) between 2 groups
Difference in number of illicit drug use between 2 groups
CNU Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: CNU interventionExperimental Treatment1 Intervention
African American/Black men who have sex with men (MSM) in same sex intimate relationships in which at least one partner is illicitly using psychostimulants and/or psychoactive substances will receive 4 sessions of CNU intervention
Group II: WP interventionActive Control1 Intervention
African American/Black men who have sex with men (MSM) in same sex intimate relationships in which at least one partner is illicitly using psychostimulants and/or psychoactive substances will receive 4 sessions of general wellness promotion (WP) intervention
Find a Location
Who is running the clinical trial?
Columbia UniversityLead Sponsor
1,433 Previous Clinical Trials
2,446,835 Total Patients Enrolled
11 Trials studying Sexually Transmitted Diseases
9,161 Patients Enrolled for Sexually Transmitted Diseases
National Institute on Drug Abuse (NIDA)NIH
2,469 Previous Clinical Trials
2,618,985 Total Patients Enrolled
19 Trials studying Sexually Transmitted Diseases
74,804 Patients Enrolled for Sexually Transmitted Diseases
Elwin Wu, PhDPrincipal InvestigatorColumbia University
1 Previous Clinical Trials
987 Total Patients Enrolled
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Share this study with friends
Copy Link
Messenger